Cart
sales@molnova.com
CJ 033466
CAS No. 519148-48-2
CJ 033466( —— )
Catalog No. M27614 CAS No. 519148-48-2
CJ 033466 is a selective partial agonist of 5-HT4 receptor (EC50 = 9 nM) with gastroprokinetic effect.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 120 | In Stock |
|
| 5MG | 98 | In Stock |
|
| 10MG | 170 | In Stock |
|
| 25MG | 271 | In Stock |
|
| 50MG | 379 | In Stock |
|
| 100MG | 509 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCJ 033466
-
NoteResearch use only, not for human use.
-
Brief DescriptionCJ 033466 is a selective partial agonist of 5-HT4 receptor (EC50 = 9 nM) with gastroprokinetic effect.
-
DescriptionCJ 033466 is a selective partial agonist of 5-HT4 receptor (EC50 = 9 nM) with gastroprokinetic effect.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
RecptorMATA2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number519148-48-2
-
Formula Weight377.92
-
Molecular FormulaC19H28ClN5O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (132.31 mM)
-
SMILESCC(C)CN1CCC(CNC(=O)c2cc(Cl)c(N)n3cc(C)nc23)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Agios. Targeting MAT2A in MTAP-deleted Cancers. Presented at the American Association for Cancer Research (AACR) Annual Meeting, April 14-18, 2018, Chicago, IL, USA
molnova catalog
related products
-
NGB2904 HCl
NGB2904 is a potent and selective antagonist of dopamine D3 receptor (Ki values are 1.4, 217, 223, 642, > 5000, > 10000 and > 10000 nM for D3, D2, 5-HT2, α1, D4, D1 and D5 receptors respectively).
-
Sumatriptan succinat...
Sumatriptan succinate is a serotonin1 (5-HT1) receptor agonist, which is effective in the acute treatment of migraine headache.
-
5-Methoxytryptamine
5-Methoxytryptamine is a tryptamine derivative that acts as a full agonist at the 5-HT1 5-HT2 5-HT4 5-HT6 and 5-HT7 receptors.
